The global electroretinography (ERG) market is emerging as a key segment within ophthalmic diagnostics, driven by rising prevalence of retinal diseases, growing demand for early intervention, and continuous technological innovation. Electroretinography — a diagnostic test that measures the electrical responses of the retina to light stimuli — plays an essential role in detecting dysfunction in retinal cells and supporting clinical decision-making for conditions ranging from retinitis pigmentosa to diabetic retinopathy.

The electroretinography market was valued at US$ 35.79 million in 2018 and it is projected to reach US$ 62.72 million in 2027; it is expected to grow at a CAGR of 6.7% from 2019 to 2027.

As eye health becomes a global priority, clinicians, researchers, and healthcare investors are increasingly focusing on ERG technologies. This surge in interest is rooted in the test’s unique ability to objectively assess retinal function — an advantage that complements conventional imaging methods like OCT (optical coherence tomography) by revealing functional changes even before structural abnormalities appear.

What Is Electroretinography and Why It Matters

Electroretinography is a non-invasive diagnostic technique that records electrical responses generated by various retinal cell types when the eye is exposed to light. By placing electrodes on the cornea or skin around the eye, clinicians can measure the retina’s response and evaluate how well it is functioning.

The electroretinography market is expanding steadily as the prevalence of retinal disorders such as diabetic retinopathy and inherited retinal dystrophies increases worldwide. Growing emphasis on early diagnosis and functional eye assessment is driving adoption of ERG systems in hospitals and specialized ophthalmology clinics.

Market Growth Drivers and Clinical Demand

The expansion of the electroretinography market is underpinned by several key factors:

1. Rising Incidence of Retinal and Degenerative Eye Diseases

Conditions such as diabetic retinopathy, age-related macular degeneration (AMD), and inherited retinal dystrophies are increasing globally due to aging populations and lifestyle-related health issues like diabetes. Since these diseases can lead to irreversible vision loss if undetected or untreated, early diagnosis through functional testing like ERG is critical.

2. Advancements in ERG Technology

Modern ERG systems have become more sophisticated, portable, and user-friendly. Innovations in electrode design, signal processing, and data interpretation have improved test accuracy and patient comfort. Portable and handheld ERG devices are lowering barriers to adoption — especially in outpatient clinics and remote care settings.

3. Integration Into Clinical Protocols

Ophthalmic practices and research institutions are increasingly incorporating ERG into routine diagnostic protocols for complex retinal conditions. The objective nature of ERG data enhances clinical confidence, aids in differential diagnosis, and supports longitudinal monitoring.

Key Technology Segments in the Market

The electroretinography market includes several distinct technology types, each tailored to specific diagnostic needs:

  • Full-Field ERG (ffERG): Measures the overall electrical response of the retina and is commonly used in diagnosing widespread retinal dysfunction.
  • Multifocal ERG (mfERG): Focuses on localized retinal areas, making it useful for mapping functional deficits and tracking disease progression.
  • Pattern ERG (PERG): Records responses linked to retinal ganglion cells, assisting in glaucoma evaluation and optic nerve assessment.

These diverse ERG modalities offer clinicians a comprehensive toolkit for assessing retinal health from multiple functional perspectives.

Applications and Clinical Use Cases

Electroretinography is used across several ophthalmic domains:

Inherited Retinal Diseases

ERG is a cornerstone diagnostic test for genetic disorders like retinitis pigmentosa and congenital stationary night blindness, where structural changes may be subtle but functional impairment is significant.

Diabetic Retinopathy Monitoring

ERG can detect early functional changes in diabetic eyes before visible structural damage occurs, providing a window for timely intervention.

Drug and Gene Therapy Evaluation

As novel treatments emerge — including gene therapies for inherited retinal diseases — ERG is increasingly used in clinical trials to measure functional outcomes and therapeutic efficacy.

Regional Market Trends

North America currently leads the global electroretinography market, driven by advanced healthcare infrastructure, strong adoption of cutting-edge diagnostic devices, and high awareness among clinicians. The presence of major ophthalmic research centers and supportive reimbursement environments further reinforces regional dominance.

Europe follows closely, with robust healthcare systems integrating ERG into specialist care pathways. Meanwhile, the Asia Pacific region is projected for rapid growth as access to eye care improves, screening programs expand, and healthcare spending rises in emerging economies.

Challenges and Market Considerations

Despite strong growth prospects, the ERG market faces certain challenges. The cost of advanced ERG systems can be a deterrent for smaller clinics, particularly in developing regions. Additionally, conducting ERG tests requires trained personnel and patient cooperation, factors that can complicate widespread adoption.

Efforts to develop simpler, less operator-dependent systems could help broaden accessibility and reduce training barriers.

Future Outlook: Opportunities on the Horizon

Looking ahead, the electroretinography market is positioned for continued innovation and expansion. Key growth opportunities include:

  • Portable and Wearable ERG Devices: Enhancing access to functional testing outside traditional clinical environments.
  • Integration with AI and Machine Learning: Enabling automated interpretation and pattern recognition for faster, more accurate diagnosis.
  • Expanded Screening Programs: Supporting early detection initiatives in both pediatric and geriatric populations.

As the importance of early and objective retinal assessment becomes more widely recognized, ERG technologies will play an increasingly pivotal role in vision care — from prevention and diagnosis to treatment monitoring.

About Us -

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Information

Email: sales@theinsightpartners.com

Also Available in : Korean German Japanese French Chinese Italian Spanish